市场调查报告书
商品编码
1433410
全球缝合锚固装置市场 2023-2030Global Suture Anchor Devices Market 2023-2030 |
预计在预测期内(2024-2031 年),全球缝合锚钉装置市场将以 4.3% 的CAGR成长。市场成长的重要因素包括骨科损伤盛行率的增加,以及在解决韧带和其他肌肉骨骼结构相关问题的手术中越来越多地使用。例如,2021 年 12 月,英国与工作相关的肌肉骨骼疾病统计报告称,2020/21 年有 47 万名工人患有与工作相关的肌肉骨骼疾病(新发或长期存在)。每 10 万名工人中有 1,420 人患有此病,占所有工作引起的健康不良的 28.0%。
全球缝合锚装置市场按材料类型、产品、捆扎类型和最终用途细分。根据材料类型,市场分为金属缝合锚钉、生物可吸收缝合锚钉等。其他包括聚醚醚酮 (PEEK) 缝合锚钉装置。根据产品,市场分为可吸收性和不可吸收性。根据打结类型,市场分为有结缝合锚钉和无结缝合锚钉。此外,根据最终用途,市场细分为医院、诊所和门诊手术中心。在材料类型中,生物可吸收缝合锚钉细分市场预计将占据相当大的市场份额,因为它降低了不良反应、发炎或排斥的风险,使其适合广泛的患者。
在捆绑类型中,无结缝合锚定的细分市场预计将在预测期内成长。该细分市场受到骨科和软组织手术中微创手术日益增长的趋势的推动,这增加了对无结缝合锚定装置的需求。无结缝合锚钉消除了手术期间打结的需要,简化了手术并降低了併发症的风险,并且因其易于使用和缩短手术时间而受到外科医生的青睐。因此,製造商都专注于推出新产品来满足市场需求。 2020 年 9 月,医疗技术公司 Smith+Nephew plc 推出了 HEALICOIL (TM) 无结缝合锚,扩展了其革命性的肩袖修復先进癒合解决方案系列。该产品组合包括创新的 REGENETEN (TM) 生物感应植入物和新型 REGENESORB (TM) 材料。 HEALICOIL 无结缝合锚的开放式架构设计与 REGENESORB 材料相结合,旨在促进骨骼癒合和形成的快速启动。
全球缝合锚定装置市场根据地理位置进一步细分,包括北美(美国和加拿大)、欧洲(英国、义大利、西班牙、德国、法国和欧洲其他地区)、亚太地区(印度、中国、日本、韩国和亚洲其他地区)以及世界其他地区(中东和非洲以及拉丁美洲)。其中,由于对缝合锚定装置的需求不断增长、老年人口不断增加、微创手术数量不断增加、政府的支持性倡议和有利的医疗保健政策,预计亚太地区将在预测期内实现增长,从而推动缝合锚定装置的成长亚太市场。
由于运动相关损伤和年龄相关骨科疾病的盛行率不断增加,预计北美将在缝合锚固装置市场中占据显着份额。根据《关节镜、运动医学和復健》杂誌报道,2022 年进行的一项研究显示,21% 的球员经历过结构性膝关节损伤,总体受伤率为每 1,000 场比赛中 5.4 次受伤。依年龄分层,结构性膝关节损伤率在20岁以下的球员中最高(3.2/1,000 GE),其次是30岁以下(3.1/1,000 GE)、25至29岁(3.0/1,000 GE)和20岁以下至 24 年 (2.3/100 GE)。以每场比赛分钟数计算,膝伤发生率最高的是上场时间超过30 分钟的球员(3.9/1,000 GE),其次是20.0 至29.9 分钟(3.0/1,000 GE)和10.0 至19.9 分钟(1.8/1,000 GE)。因此,老年人口的增加与骨科手术的增加有关,从而推动了该地区研究的市场。 2022年4月,加拿大统计局发表文章《2021年人口普查显示加拿大85岁以上人口成长概况》,全国65岁以上人口有730万人。此外,在未来 25 年(到 2046 年),85 岁及以上的人口可能会增加两倍,达到近 250 万人。
服务于缝合锚定装置市场的主要公司包括 Arthrex, Inc.、ConMed Corp.、Johnson and Johnson (DePuy Synthes, Inc.)、Smith & Nephew plc 等。市场参与者透过各种策略(包括併购、合作、合作、融资和新产品发布),为市场成长做出了巨大贡献,以保持市场竞争力。例如,2022 年 12 月,Stryker Corp. 推出了 Citrefix (TM),这是一种用于足部和踝关节外科手术的缝合锚钉系统。新系统使用了 Citregen (TM),这是一种生物可吸收材料,旨在模仿天然骨骼的化学和结构。
Global Suture Anchor Devices Market Size, Share & Trends Analysis Report by Material Type (Metallic Suture Anchor, Bio-Absorbable Suture Anchor, and Others), by Product (Absorbable, and Non-Absorbable), by Tying Type (Knotted Suture Anchors, and Knotless Suture Anchors), by End-Use (Hospitals, Clinics, and Ambulatory Surgical Centers), Forecast Period (2024-2031)
The global suture anchor devices market is anticipated to grow at a CAGR of 4.3% during the forecast period (2024-2031). Significant factors attributed to market growth includes increasing prevalence of orthopedic injuries, and growing use in procedures to address issues related to ligaments, and other musculoskeletal structures. For instance, iIn December 2021, Work-Related Musculoskeletal Disorders Statistics in Great Britain reported that 4,70,000 workers suffered from work-related musculoskeletal disorders (new or long-standing) in 2020/21. This represents 1,420 per 100,000 workers and thus accounts for 28.0% of all work-induced ill health.
The global suture anchor devices market is segmented on the by material type, product, tying type, and end-use. Based on the material type, the market is sub-segmented into metallic suture anchor, bio-absorbable suture anchor, and others. Others include polyetheretherketone (PEEK) suture anchor devices. Based on the product, the market is sub-segmented into absorbable, and non-absorbable. Based on the tying type, the market is sub-segmented into knotted suture anchors, and knotless suture anchors. Further, based on end-use, the market is sub-segmented into hospitals, clinics, and ambulatory surgical centers. Among the material type, the bio-absorbable suture anchor sub-segment is anticipated to hold a considerable share of the market, owing to the reducing the risk of adverse reactions, inflammation, or rejection, making them suitable for a wide range of patients.
Among the tying type, knotless suture anchors sub-segments expected to grow over the forecast period. The segment is driven by the growing trend towards minimally invasive procedures in orthopedic and soft tissue surgeries contributes to the demand for knotless suture anchor devices. Knotless suture anchors eliminate the need for tying knots during surgery, simplifying the procedure, and reducing the risk of complications, and are preferred by surgeons for their ease of use and potential for faster surgical times. Thus, the manufacturers are emphasizing on launching new products to cater to the demand in the market. In September 2020, Smith+Nephew plc, the medical technology business, launched the HEALICOIL™ KNOTLESS Suture Anchor, expanding its revolutionary line of advanced healing solutions for rotator cuff repair. This portfolio included the innovative REGENETEN™ Bioinductive Implant and novel REGENESORB™ Material. The open architecture design of the HEALICOIL KNOTLESS Suture Anchor coupled with REGENESORB Material was designed to facilitate a jump start in bone healing and formation.
The global suture anchor devices market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to grow over the forecast period, owing to the growing demand for suture anchor devices, increasing geriatric population, growing number of minimally invasive procedures, supportive government initiatives, and favorable healthcare policies, driving the suture anchor devices market in the Asia-Pacific.
North America is expected to hold a prominent share in the suture anchor devices market, owing to the increasing prevalence of sports-related injuries and age-related orthopedic conditions. As reported in the Arthroscopy, Sports Medicine, and Rehabilitation journal, a study conducted in 2022 revealed that 21% of players experienced structural knee injuries, with an overall injury rate of 5.4 injuries per 1,000 game exposures. Stratified by age, structural knee injury rate was greatest in players less than 20 years old (3.2/1,000 GE) followed by less than 30 years old (3.1/1,000 GE), 25 to 29 years (3.0/1,000 GE), and 20 to 24 years (2.3/100 GE). Knee injury by minutes per game, the rate was greatest in those playing more than 30 minutes (3.9/1,000 GE), followed by 20.0 to 29.9 minutes (3.0/1,000 GE), and 10.0 to 19.9 minutes (1.8/1,000 GE). Thus, an increasing geriatric population is associated with an increase in orthopedic surgeries, thus boosting the market studied in the region. In April 2022, Statistics Canada published the article "A portrait of Canada's growing population aged 85 and older from the 2021 Census", that there were 7.3 million people aged 65 and older in the country. Furthermore, over the next 25 years (by 2046), the population aged 85 and above may get triple to almost 2.5 million people.
The major companies serving the suture anchor devices market include Arthrex, Inc., ConMed Corp., Johnson and Johnson (DePuy Synthes, Inc.), Smith & Nephew plc, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in December 2022, Stryker Corp., launched the Citrefix™, a suture anchor system for foot and ankle surgical procedures. The new system used Citregen™, a bioresorbable material designed to mimic the chemistry and structure of native bone.